Celanese Publishes 2021-2022 Sustainability Report and Index
Celanese Expands Capabilities to Support the Sustained-Release Drug Delivery Market
Celanese to Hold Third Quarter Earnings Conference Call on November 4, 2022
Ravago Selected as North American Distributor for Celanese Santoprene® and Geolast® TPV
Celanese Announces Grant Award to Develop Long-Acting, Refillable Drug Delivery Solution
Celanese Corporation Reports Second Quarter 2022 Earnings; Reaffirms Full Year 2022 Outlook
Celanese Corporation Declares Quarterly Dividend of $0.68 per share
Celanese Corporation Prices an Additional €1.5 Billion of Permanent Financing for DuPont M&M Acquisition
Celanese Corporation Prices $7.5 Billion of Permanent Financing for DuPont M&M Acquisition
Celanese to Hold Second Quarter Earnings Conference Call on July 29, 2022
